title: Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis.
authors.affiliation: Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU. csudlow@skull.dcn.ed.ac.uk
authors.forename: Cathie L M
authors.initials: CL
authors.lastname: Sudlow
authors.forename: Carl E
authors.initials: CE
authors.lastname: Counsell
mesh_terms: D015982:Bias; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D004341:Drug Evaluation / Q000191:economics; D006076:Government; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000191:economics; D019057:Quality-Adjusted Life Years; D020414:Risk Sharing, Financial; D006113:United Kingdom